# ZBP1 as a dynamic monitor of viral replication: implications for therapeutic strategies

**Authors:** Zhiying Ou, Yanfeng Huang, Xi Xue, Huiling Zhou, Shuihong Li, Kangpeng Xiao

PMC · DOI: 10.3389/fcimb.2026.1758221 · Frontiers in Cellular and Infection Microbiology · 2026-02-09

## TL;DR

ZBP1 acts as a dynamic immune sensor during viral replication, offering new insights for developing targeted antiviral therapies.

## Contribution

The paper presents ZBP1 as a dynamic monitor of viral replication, emphasizing its role in spatiotemporal signaling and therapeutic potential.

## Key findings

- ZBP1's subcellular localization determines its signaling outcome, such as nuclear or cytoplasmic sensing.
- ZBP1 uses amyloid assembly to concentrate kinases and initiate cell death, overcoming cellular inhibition.
- ZBP1's dual antiviral strategy includes inflammation and PANoptotic cell death, countered by viral mechanisms like signal masking and interception.

## Abstract

Z-DNA binding protein 1 (ZBP1) is an innate immune sensor that recognizes Z-NAs, an atypical, left-handed nucleic acid structure produced during viral replication. This review contextualizes ZBP1 function within the spatiotemporal dynamics of the viral replication cycle, portraying it as a dynamic monitor rather than a static alarm. We discuss how the subcellular localization determines the signaling outcome (e.g., nuclear versus cytoplasmic sensing). Specifically, we discuss how ZBP1 functions as a dynamic molecular scaffold, where ligand-induced amyloid assembly concentrates downstream kinases to overcome cellular inhibition and initiate cell death. The review details ZBP1’s dual antiviral strategy, encompassing NF-κB-mediated inflammation and PANoptotic cell death, and the resulting co-evolutionary dynamics, characterized by viral countermeasures such as ‘signal masking’ seen in poxvirus E3 and ‘signal interception’ utilized by herpesvirus ICP6. Finally, the dual immunomodulatory role of ZBP1 in driving immunopathology is analyzed. This replication-centric perspective provides a theoretical foundation for developing precise, stage-based therapies targeting the ZBP1 pathway.

## Linked entities

- **Genes:** ZBP1 (Z-DNA binding protein 1) [NCBI Gene 81030]
- **Proteins:** ZBP1 (Z-DNA binding protein 1), NFKB1 (nuclear factor kappa B subunit 1), ALDH9A1 (aldehyde dehydrogenase 9 family member A1)

## Full-text entities

- **Genes:** IL1B (interleukin 1 beta) [NCBI Gene 3553] {aka IL-1, IL1-BETA, IL1F2, IL1beta}, TBK1 (TANK binding kinase 1) [NCBI Gene 29110] {aka AIARV, FTDALS4, IIAE8, NAK, T2K}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, IL18 (interleukin 18) [NCBI Gene 3606] {aka IGIF, IL-18, IL-1g, IL1F4}, GSDMD (gasdermin D) [NCBI Gene 79792] {aka DF5L, DFNA5L, FKSG10, GSDMDC1}, IL33 (interleukin 33) [NCBI Gene 90865] {aka C9orf26, DVS27, IL1F11, NF-HEV, NFEHEV}, RIPK3 (receptor interacting serine/threonine kinase 3) [NCBI Gene 11035] {aka RIP3}, STING1 (stimulator of interferon response cGAMP interactor 1) [NCBI Gene 340061] {aka ERIS, MITA, MPYS, NET23, SAVI, STING}, MLKL (mixed lineage kinase domain like pseudokinase) [NCBI Gene 197259] {aka hMLKL}, MUL1 (mitochondrial E3 ubiquitin protein ligase 1) [NCBI Gene 79594] {aka C1orf166, GIDE, MAPL, MULAN, RNF218}, FADD (Fas associated via death domain) [NCBI Gene 8772] {aka GIG3, IMD90, MORT1}, IFNA8 (interferon alpha 8) [NCBI Gene 3445] {aka IFN-alphaB}, NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790] {aka CVID12, EBP-1, KBF1, NF-kB, NF-kB1, NF-kappa-B1}, CGAS (cyclic GMP-AMP synthase) [NCBI Gene 115004] {aka C6orf150, D4, MB21D1, h-cGAS}, CASP1 (caspase 1) [NCBI Gene 834] {aka ICE, IL1BC, P45}, JAK1 (Janus kinase 1) [NCBI Gene 3716] {aka AIIDE, JAK1A, JAK1B, JTK3}, NLRP3 (NLR family pyrin domain containing 3) [NCBI Gene 114548] {aka AGTAVPRL, AII, AVP, C1orf7, CIAS1, CLR1.1}, IRF3 (interferon regulatory factor 3) [NCBI Gene 3661] {aka IIAE7}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, CASP8 (caspase 8) [NCBI Gene 841] {aka ALPS2B, CAP4, Casp-8, FLICE, MACH, MCH5}, RIPK1 (receptor interacting serine/threonine kinase 1) [NCBI Gene 8737] {aka AIEFL, IMD57, RIP, RIP-1, RIP1}, ZBP1 (Z-DNA binding protein 1) [NCBI Gene 81030] {aka C20orf183, DAI, DLM-1, DLM1}, NFKBIA (NFKB inhibitor alpha) [NCBI Gene 4792] {aka EDAID2, IKBA, MAD-3, NFKBI}, TNFRSF1A (TNF receptor superfamily member 1A) [NCBI Gene 7132] {aka CD120a, FPF, TBP1, TNF-R, TNF-R-I, TNF-R55}, MPLKIP (M-phase specific PLK1 interacting protein) [NCBI Gene 136647] {aka ABHS, C7orf11, ORF20, TTD4}, HMGB1 (high mobility group box 1) [NCBI Gene 3146] {aka HMG-1, HMG1, HMG3, SBP-1}, JAK2 (Janus kinase 2) [NCBI Gene 3717] {aka JTK10}
- **Diseases:** neuroinflammatory diseases (MESH:D000090862), Alzheimer's (MESH:D000544), Respiratory Diseases (MESH:D012140), IAV infection (MESH:D007251), inflammation (MESH:D007249), COVID-19 (MESH:D000086382), Infection (MESH:D007239), viral (MESH:D014777), ALS (MESH:D008113), SFTSV (MESH:D000085142), tissue injury (MESH:D017695)
- **Chemicals:** CBL0137 (MESH:C000600493), birinapant (MESH:C582429), DNL104 (-), Z (MESH:C000597310), 5-azacytidine (MESH:D001374), DAMPs (MESH:C116255), Baricitinib (MESH:C000596027)
- **Species:** Suid alphaherpesvirus 1 (no rank) [taxon 10345], Human alphaherpesvirus 1 (Herpes simplex virus type 1, no rank) [taxon 10298], Orthopoxvirus vaccinia (species) [taxon 10245], Human alphaherpesvirus 3 (Varicella-zoster virus, no rank) [taxon 10335], Severe acute respiratory syndrome coronavirus 2 (no rank) [taxon 2697049], Herpesvirus [taxon 39059], Equid alphaherpesvirus 1 (Equine herpesvirus 1, no rank) [taxon 10326], Homo sapiens (human, species) [taxon 9606], Reovirus sp. (species) [taxon 10891], Influenza A virus (no rank) [taxon 11320]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12926395/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12926395/full.md

## References

82 references — full list in the complete paper: https://tomesphere.com/paper/PMC12926395/full.md

---
Source: https://tomesphere.com/paper/PMC12926395